Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study
This study identified that dupilumab was effective in real life, even outside of the controlled environments of pivotal studies. Additionally, despite conjunctivitis being a common adverse event, no patient required treatment discontinuation.
Authors
- Jorge Kalil (ORCID: https://orcid.org/0000-0001-8415-4274)
- Mariele Morandin Lopes (ORCID: https://orcid.org/0000-0002-3014-3470)
- Túlio Morandin Ferrisse (ORCID: https://orcid.org/0000-0002-9933-2819)
- Ana Paula Moschione Castro
- Fábio Morato Castro (ORCID: https://orcid.org/0000-0002-6211-5773)
- Ariana Campos Yang (ORCID: https://orcid.org/0000-0002-1901-3472)
Institutions
- Universidade de São Paulo (BR)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- Drugs in Context
- Published
- 2025-06-17
- DOI
- https://doi.org/10.7573/dic.2025-3-5
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00